𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of lomeguatrib–temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells

✍ Scribed by Taspinar, Mehmet; Ilgaz, Seda; Ozdemir, Mevci; Ozkan, Tulin; Oztuna, Derya; Canpinar, Hande; Rey, Juan A.; Sunguroğlu, Asuman; Castresana, Javier S.; Ugur, Hasan Caglar

Book ID
120061356
Publisher
S. Karger AG
Year
2013
Tongue
English
Weight
710 KB
Volume
34
Category
Article
ISSN
1010-4283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Promoter methylation and expression of M
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
✍ Jörg Felsberg; Niklas Thon; Sabina Eigenbrod; Bettina Hentschel; Michael C. Sabe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 534 KB

## Abstract Epigenetic silencing of the O^6^‐methylguanine‐DNA methyltransferase (__MGMT__) gene promoter is associated with prolonged survival in glioblastoma patients treated with temozolomide (TMZ). We investigated whether glioblastoma recurrence is associated with changes in the promoter methyl

Comparison of effect of tumor promoter t
Comparison of effect of tumor promoter treatments on DNA methylation status and gene expression in B6C3F1 and C57BL/6 mouse liver and in B6C3F1 mouse liver tumors
✍ Jennifer L. Counts; R. Michael McClain; Jay I. Goodman 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views

The effects of different liver tumor-promoting treatments (i.e., a choline-devoid, methionine-deficient (CMD) diet, phenobarbital (PB), or both) on Ha-ras and raf methylation status and expression were determined in mouse strains with different susceptibilities to liver tumor formation: the relative